A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients
Clinical trial NCT05075304 · TERMINATED
Trial details
- NCT number
- NCT05075304
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-21
- Primary completion
- 2020-04-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.